Summit Financial Strategies, Inc. Pfizer Inc Transaction History

Summit Financial Strategies, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $209,351 - $242,214	5,796 New	5,796 $212,000
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $103,448 - $126,284	2,364 Added 51.07%	6,993 $306,000
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $29,500 - $34,977	634 Added 15.87%	4,629 $243,000
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $11,208 - $13,889	-245 Reduced 5.78%	3,995 $207,000
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $175,196 - $259,700	4,240 New	4,240 $250,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $180,254 - $233,737	-5,548 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $10,909 - $12,248	-295 Reduced 5.05%	5,548 $240,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $201,408 - $244,295	5,843 New	5,843 $258,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Summit Financial Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on Summit Financial Strategies, Inc. with notifications on news.